Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genome-wide shRNA screen revealed integrated mitogenic signaling between dopamine receptor D2 (DRD2) and epidermal growth factor receptor (EGFR) in glioblastoma

28 Feb 2014

Abstract excerpt

// Jie Li 1,* , Shan Zhu 2,* , David Kozono 2,* , Kimberly Ng 1 , Diahnn Futalan 1 , Ying Shen 1 , Johnny C. Akers 1 , Tyler Steed 1 , Deepa Kushwaha 2 , Michael Schlabach 3 , Bob S. Carter 1 , Chang-Hyuk Kwon 4 , Frank Furnari 5 , Webster Cavenee 5 , Stephen Elledge 6 , Clark C. Chen 1 1 Center for Translational and Applied Neuro-oncology, Division of Neurosurgery, University of California, San Diego, CA 2...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Brain Metastases and Treatment
Share to Cancer Genomics and Diagnostics
Share to Glioma Diagnosis and Treatment

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 24658464
DOI: 10.18632/oncotarget.1801

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genome-wide shRNA screen revealed integrated mitogenic signaling between dopamine receptor D2 (DRD2) and epidermal growth factor receptor (EGFR) in glioblastomaPMID 24658464Read ↗

Epidermal growth factor receptor as a molecular determinant of glioblastoma response to dopamine receptor D2 inhibitorsSemantic proximity Read ↗

Dopamine receptor D2 regulates glioblastoma survival and death through MET and death receptor 4/5Semantic proximity Read ↗

Activation of dopamine receptor 2 (DRD2) prompts transcriptomic and metabolic plasticity in glioblastomaSemantic proximity Read ↗

N‐Myc downstream‐regulated gene 2 <i>(NDRG2)</i> inhibits glioblastoma cell proliferationSemantic proximity Read ↗

KDELR2 Promotes Glioblastoma Tumorigenesis Targeted by HIF1a via mTOR Signaling PathwaySemantic proximity Read ↗

Dopamine Receptor D5 is a Modulator of Tumor Response to Dopamine Receptor D2 AntagonismSemantic proximity Read ↗

The Dopamine D2 Receptor Contributes to the Spheroid Formation Behavior of U87 Glioblastoma Cells.Semantic proximity Read ↗

RND2 attenuates apoptosis and autophagy in glioblastoma cells by targeting p38 MAPK signaling pathwaySemantic proximity Read ↗

p53 and miR‐210 regulated NeuroD2, a neuronal basic helix–loop–helix transcription factor, is downregulated in glioblastoma patients and functions as a tumor suppressor under hypoxic microenvironmentSemantic proximity Read ↗

Loss of CD99L2 contributed to temozolomide resistance and glioblastoma tumorigenesis based on Genome-scale CRISPR/Cas9 screeningSemantic proximity Read ↗

Synergistic Effects of the DRD2/3 Antagonist ONC201 and Radiation in GlioblastomaSemantic proximity Read ↗

RRM2 promotes the progression of human glioblastomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.